Figure 3.
Osmoscan profile in splenectomized patients. (A) Shaded area = control range curve; Dashed area = splenectomised patients (seven affected by PKD, two by Pyr5′N deficiency and seven by CDAII); (B) CDAII: non-splenectomised (), splenectomised (
); (C) PKD: non-splenectomised (
), splenectomised (
); (D) Pyr5′N deficiency: non-splenectomised (
), splenectomised (
).